An Open Label, Phase II Trial of Afatinib with Paclitaxel for the Neoadjuvant Treatment of Triple-Negative Breast Cancer and Research of Biomarkers of Activity and Efficacy of Afatinib( III )
Project title
評估Afatinib合併太平洋紫杉醇用於三陰性乳癌之術前治療第II期臨床試驗的療效並尋求可預測Afatinib有效性之生物標記( III )
